Emfo, LLC Amgen Inc Transaction History

Emfo, LLC

$110 Million
Q2 2024

A detailed history of Emfo, LLC transactions in Amgen Inc stock. As of the latest transaction made, Emfo, LLC holds 7,299 shares of AMGN stock, worth $2.3 Million. This represents 2.07% of its overall portfolio holdings.

Number of Shares

7,299

Previous 5,799 25.87%

Holding current value

$2.3 Million

Previous $1.65 Million 38.35%

% of portfolio

2.07%

Previous 1.52%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$262.75 - $319.31 $394,125 - $478,965	1,500 Added 25.87%	7,299 $2.28 Million
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $703,397 - $873,286	3,217 Added 124.59%	5,799 $1.56 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $535,675 - $633,425	2,500 Added 3048.78%	2,582 $573,000
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $1.69 Million - $1.93 Million	-8,480 Reduced 99.04%	82 $18,000
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $139,885 - $163,893	659 Added 8.34%	8,562 $1.82 Million
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $1.85 Million - $2.05 Million	7,903 New	7,903 $1.93 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emfo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emfo, LLC with notifications on news.

Account